Macrolide myths

Current Opinion in Microbiology

Volumn 11, Issue 5, 2008, Pages 414-421

  Mankin, Alexander S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; KETOLIDE; MACROLIDE; RIBOSOME PROTEIN; RIBOSOME RNA; TELITHROMYCIN; TYLOSIN;

BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BINDING SITE; CRYSTALLOGRAPHY; DEINOCOCCUS RADIODURANS; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; ESCHERICHIA COLI; HALOBACTERIUM SALINARUM; HUMAN; NONHUMAN; OPEN READING FRAME; PROTEIN SYNTHESIS INHIBITION; REVIEW; RIBOSOME; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; MACROLIDES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN BIOSYNTHESIS; RIBOSOMES;

EID: 55049123651     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2008.08.003     Document Type: Review

References (36)

1. Moazed D., and Noller H.F. Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie 69 (1987) 879-884
2. Sigmund C.D., and Morgan E.A. Erythromycin resistance due to mutation in a ribosomal RNA operon of Escherichia coli. Proc Natl Acad Sci U S A 79 (1982) 5602-5606
3. Vester B., and Garrett R.A. A plasmid-coded and site-directed mutation in Escherichia coli 23S RNA that confers resistance to erythromycin: implications for the mechanism of action of erythromycin. Biochimie 69 (1987) 891-900
4. Vester B., and Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 45 (2001) 1-12
5. Hansen L.H., Mauvais P., and Douthwaite S. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA. Mol Microbiol 31 (1999) 623-632
6. Xiong L., Shah S., Mauvais P., and Mankin A.S. A ketolide resistance mutation in domain II of 23S rRNA reveals proximity of hairpin 35 to the peptidyl transferase centre. Mol Microbiol 31 (1999) 633-639
7. Schlunzen F., Harms J.M., Franceschi F., Hansen H.A., Bartels H., Zarivach R., and Yonath A. Structural basis for the antibiotic activity of ketolides and azalides. Structure 11 (2003) 329-338
8. Schlunzen F., Zarivach R., Harms J., Bashan A., Tocilj A., Albrecht R., Yonath A., and Franceschi F. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413 (2001) 814-821. The first crystallographic structure of macrolide-ribosome complexes.
9. Hansen J.L., Ippolito J.A., Ban N., Nissen P., Moore P.B., and Steitz T.A. The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol Cell 10 (2002) 117-128
10. Tu D., Blaha G., Moore P.B., and Steitz T.A. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Cell 121 (2005) 257-270. Currently, the highest resolution structures of macrolide antibiotics complexed to the ribosomal subunit.
11. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 39 (1995) 577-585
12. Berisio R., Harms J., Schluenzen F., Zarivach R., Hansen H.A., Fucini P., and Yonath A. Structural insight into the antibiotic action of telithromycin against resistant mutants. J Bacteriol 185 (2003) 4276-4279
13. Poulsen S.M., Kofoed C., and Vester B. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin. J Mol Biol 304 (2000) 471-481
14. Mao J.C.-H., and Robishaw E.E. Effects of macrolides on peptide-bond formation and translocation. Biochemistry 10 (1971) 2054-2061
15. Menninger J.R., and Otto D.P. Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes. Antimicrob Agents Chemother 21 (1982) 810-818
16. Otaka T., and Kaji A. Release of (oligo) peptidyl-tRNA from ribosomes by erythromycin A. Proc Natl Acad Sci U S A 72 (1975) 2649-2652
17. Tenson T., Lovmar M., and Ehrenberg M. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J Mol Biol 330 (2003) 1005-1014. The accurate characterization of peptidyl-tRNAs dissociated from the ribosome because of macrolide-induced drop-off.
18. Champney W.S., and Burdine R. Macrolide antibiotics inhibit 50S ribosomal subunit assembly in Bacillus subtilis and Staphylococcus aureus. Antimicrob Agents Chemother 39 (1995) 2141-2144
19. Douthwaite S., Hansen L.H., and Mauvais P. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. Mol Microbiol 36 (2000) 183-193
20. Xiong L., Korkhin Y., and Mankin A.S. Binding site of the bridged macrolides in the Escherichia coli ribosome. Antimicrob Agents Chemother 49 (2005) 281-288
21. Pfister P., Corti N., Hobbie S., Bruell C., Zarivach R., Yonath A., and Bottger E.C. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G. Proc Natl Acad Sci U S A 102 (2005) 5180-5185
22. Bommakanti A.S., Lindahl L., and Zengel J.M. Mutation from guanine to adenine in 25S rRNA at the position equivalent to E. coli A2058 does not confer erythromycin sensitivity in Sacchromyces cerevisae. RNA 14 (2008) 460-464
23. Mayford M., and Weisblum B. ermC leader peptide. Amino acid sequence critical for induction by translational attenuation. J Mol Biol 206 (1989) 69-79
24. Vazquez-Laslop N., Thum C., and Mankin A.S. Molecular mechanism of drug-dependent ribosome stalling. Mol Cell 30 (2008) 190-202
25. Gregory S.T., and Dahlberg A.E. Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23 S ribosomal RNA. J Mol Biol 289 (1999) 827-834
26. Gabashvili I.S., Gregory S.T., Valle M., Grassucci R., Worbs M., Wahl M.C., Dahlberg A.E., and Frank J. The polypeptide tunnel system in the ribosome and its gating in erythromycin resistance mutants of L4 and L22. Mol Cell 8 (2001) 181-188
27. Tenson T., and Mankin A.S. Antibiotics and the ribosome. Mol Microbiol 59 (2006) 1664-1677
28. Weisblum B. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob Agents Chemother 39 (1995) 797-805
29. Kwon A.R., Min Y.H., Yoon E.J., Kim J.A., Shim M.J., and Choi E.C. ErmK leader peptide: amino acid sequence critical for induction by erythromycin. Arch Pharm Res 29 (2006) 1154-1157
30. Tenson T., DeBlasio A., and Mankin A. A functional peptide encoded in the Escherichia coli 23S Rrna. Proc Natl Acad Sci U S A 93 (1996) 5641-5646
31. Tripathi S., Kloss P.S., and Mankin A.S. Ketolide resistance conferred by short peptides. J Biol Chem 273 (1998) 20073-20077
32. Lovmar M., Nilsson K., Vimberg V., Tenson T., Nervall M., and Ehrenberg M. The molecular mechanism of peptide-mediated erythromycin resistance. J Biol Chem 281 (2006) 6742-6750
33. Tenson T., Xiong L., Kloss P., and Mankin A.S. Erythromycin resistance peptides selected from random peptide libraries. J Biol Chem 272 (1997) 17425-17430
34. Lovmar M., Tenson T., and Ehrenberg M. Kinetics of macrolide action: the josamycin and erythromycin cases. J Biol Chem 279 (2004) 53506-53515
35. Macvanin M., Gonzalez de Valdivia E.I., Ardell D.H., and Isaksson L.A. Transient erythromycin resistance phenotype associated with peptidyl-tRNA drop-off on early UGG and GGG codons. J Bacteriol 189 (2007) 8993-9000
36. Jenni S., and Ban N. The chemistry of protein synthesis and voyage through the ribosomal tunnel. Curr Opin Struct Biol 13 (2003) 212-219